In a 38-year-old female with major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, and a history of marijuana use who is taking cariprazine (Vraylar) 3 mg daily, clonazepam 1 mg as needed, and vilazodone 40 mg daily, what specific questions should I ask during the initial evaluation to assess for attention-deficit/hyperactivity disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ADHD Screening Questions for Initial Evaluation

In this 38-year-old female with complex psychiatric comorbidities including MDD, GAD, PTSD, and marijuana use, you should systematically assess for ADHD by establishing childhood-onset symptoms before age 12, current functional impairment across multiple settings, and carefully distinguishing ADHD symptoms from her existing conditions that can mimic inattention and hyperactivity.

Critical Diagnostic Framework

1. Establish Childhood Onset (Required by DSM-5)

You must document symptoms present before age 12 1:

  • "Thinking back to elementary school, did you have trouble paying attention, staying organized, or sitting still compared to other kids your age?"
  • "Did teachers comment on report cards about you being distracted, not finishing work, or being fidgety?"
  • "Were you ever held back a grade or need special help in school?"
  • "Did you lose things frequently as a child, forget homework, or have trouble following through on chores?"

Critical pitfall: Without documented childhood symptoms, ADHD cannot be diagnosed per DSM-5 criteria, even if current symptoms are present 1.

2. Current Symptom Assessment

Inattention Domain (ask about at least 6 symptoms):

  • "Do you have difficulty sustaining attention during tasks or conversations?"
  • "Do you make careless mistakes at work or miss important details?"
  • "Does your mind wander when people are speaking directly to you?"
  • "Do you start projects but struggle to finish them?"
  • "Do you avoid tasks requiring sustained mental effort?"
  • "Do you frequently lose important items (keys, phone, bills)?"
  • "Are you easily distracted by external stimuli or unrelated thoughts?"
  • "Do you forget daily activities, appointments, or to return calls?"

Hyperactivity/Impulsivity Domain (ask about at least 6 symptoms):

  • "Do you feel restless or fidgety, like you need to move?"
  • "Do you have trouble staying seated in situations where it's expected?"
  • "Do you feel driven by a motor or 'on the go'?"
  • "Do you talk excessively?"
  • "Do you blurt out answers before questions are completed?"
  • "Do you have difficulty waiting your turn?"
  • "Do you interrupt or intrude on others' conversations?"

Note: In adults, hyperactivity often manifests as internal restlessness rather than overt motor activity 1.

3. Functional Impairment Across Settings

ADHD requires impairment in at least two settings 1:

  • Work/School: "How do these symptoms affect your job performance? Do you miss deadlines, make errors, or have trouble with organization?"
  • Home: "Do these symptoms cause problems managing household tasks, paying bills, or maintaining your living space?"
  • Relationships: "Do these symptoms create conflict in relationships—forgetting important dates, not listening, interrupting?"

4. Rule Out Mimicking Conditions (Essential in This Patient)

This is critically important given her psychiatric history 1:

Distinguish from Current Conditions:

PTSD can mimic ADHD 1:

  • "When you have trouble concentrating, is it specifically related to trauma memories or hypervigilance, or is it present even when you're not triggered?"
  • "Does your restlessness worsen with trauma reminders or is it constant regardless of triggers?"

Marijuana use can mimic ADHD 1:

  • "When did you last use marijuana? How frequently do you use it?"
  • "Were attention problems present before you started using marijuana, or did they begin afterward?"
  • "Do symptoms improve or worsen when you're not using?"

Depression/Anxiety can cause pseudo-ADHD 1:

  • "Did attention and concentration problems exist before your depression/anxiety began?"
  • "When your mood is better, do concentration problems persist?"
  • "Is your restlessness specifically related to anxiety or present even when calm?"

Medication effects 2:

  • Vraylar (cariprazine) can cause akathisia (restlessness) that mimics hyperactivity 3
  • Ask: "Did restlessness begin or worsen after starting Vraylar?"
  • Benzodiazepines can impair cognition
  • Ask: "How often do you take clonazepam? Do you notice cognitive dulling?"

5. Obtain Collateral Information

You cannot rely solely on self-report 1:

  • Request permission to contact family members who knew her as a child
  • Ask: "Can I speak with a parent or sibling who remembers your childhood behavior?"
  • Obtain old report cards if available
  • Consider standardized rating scales (though guidelines note these are for children/adolescents, they can inform adult assessment)

Key Clinical Caveats

Timing Considerations:

  • Do not diagnose ADHD during acute psychiatric instability 1. Her current medication regimen suggests active symptom management.
  • Reassess after mood/anxiety symptoms are optimized and marijuana use is addressed.

Gender Considerations:

  • Women with ADHD more commonly present with inattentive symptoms and comorbid anxiety/depression 1
  • They may have been missed in childhood due to less disruptive behavior

Substance Use Red Flag:

  • Marijuana effects can persist and mimic ADHD 1
  • Some patients may feign ADHD symptoms to obtain stimulants 1
  • Document timeline carefully: symptoms before substance use vs. after

Structured Assessment Approach

  1. First, establish childhood onset (mandatory for diagnosis)
  2. Then, assess current symptoms systematically across both domains
  3. Document functional impairment in multiple settings
  4. Rule out mimics (PTSD, substances, medications, mood/anxiety)
  5. Obtain collateral information from childhood observers
  6. Consider deferring diagnosis until mood/anxiety/PTSD symptoms are better controlled and substance use is addressed

If symptoms are clearly present only during periods of depression, anxiety, or PTSD exacerbation, or began after marijuana use or medication initiation, ADHD is unlikely 1.

Related Questions

How should I manage the medications for a 53-year-old man with severe chronic depressive episode, bipolar II disorder, generalized anxiety disorder, and complex PTSD who is taking cariprazine 6 mg daily, duloxetine 90 mg daily, lamotrigine 200 mg twice daily, clonazepam 2 mg three times daily, bupropion (Wellbutrin) 50 mg daily, and quetiapine (Seroquel) 150 mg injection for sleep?
How does Vraylar (cariprazine) work in bipolar disorder?
Can cariprazine be used to treat hypomanic episodes in bipolar II disorder?
Can Vraylar (cariprazine) be initiated as monotherapy for treatment‑resistant depression?
Is Vraylar (cariprazine) a mood stabilizer for bipolar disorder?
Which of the following is NOT an indication for thyroid nodule fine‑needle aspiration: a nodule increasing in size over time, nodules larger than 1 cm with suspicious ultrasound features, nodules associated with abnormal ipsilateral lymph nodes, a 0.4 cm nodule, or nodules larger than 1.5 cm with mixed cystic‑solid ultrasound features?
What is the physiologic newborn skin desquamation (newborn skin peeling) condition?
What is the recommended dosing, monitoring, and contraindications for NUBEQA (darolutamide) in patients with non‑metastatic castration‑resistant prostate cancer receiving continuous androgen‑deprivation therapy?
What is the generic name of Actos (pioglitazone)?
What is the recommended surveillance imaging schedule after curative resection for stage II colon cancer that is microsatellite instability‑high (MSI‑high) and has a BRAF mutation?
Is standard troponin I screening useful in patients aged 65 years or older or with a Revised Cardiac Risk Index ≥ 1 undergoing major vascular or intermediate‑risk non‑cardiac surgery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.